Atlas Trials

The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

Clinical trial NCT02935998 · UNKNOWN

Trial details

NCT number
NCT02935998
Sponsor
Yang Fude
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2016-10-01
Primary completion
2017-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.